Printer Friendly

Browse T cells topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Regeneron announces initial data from Phase 1/2 trial of REGN5678 with Libtayo. Aug 3, 2022 613
HCW Biologics announces US issued patent for platform technology. Aug 3, 2022 204
LATEST COMPANY NEWS. Aug 3, 2022 16743
Update on the Classification of and Diagnostic Approaches to Mature T-Cell Lymphomas. Zhang, Xiaohui; Zhou, Jiehao; Han, Xin; Wang, Endi; Zhang, Linsheng Aug 1, 2022 5518
TEVOGEN BIO ESTABLISHES PHILADELPHIA R&D CENTER. Jul 30, 2022 506
Effect of Intervention of Probiotics in Advance on Treg/Th17 in Premature Mice. Liu, Mengmeng; Mao, Juanjuan; Zhang, Shifa Jul 30, 2022 4699
SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia. Ngalamika, Owen; Mukasine, Marie Claire; Kamanzi, Patrick; Kawimbe, Musonda; Mujajati, Aaron; Tso, F Jul 28, 2022 5804
Intratumoral IL-28B Gene Delivery Elicits Antitumor Effects by Remodeling of the Tumor Microenvironment in H22-Bearing Mice. Li, Zhi; Wang, Jianghua; Chen, Chong; He, Qi; Xu, Xiaoying; Da, Zejiao; Wang, Bo Jul 28, 2022 7382
Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases. Shandil, Radha Krishan; Dhup, Saumya; Narayanan, Shridhar Jul 28, 2022 7604
In8bio provides clinical update from ongoing Phase 1 trial of INB-100. Jul 27, 2022 224
Kite's CAR T-cell Therapy Tecartus Receives Positive CHMP Opinion in Relapsed or Refractory Acute Lymphoblastic Leukemia. Jul 26, 2022 527
MRGBP: A New Factor for Diagnosis and Prediction of Head and Neck Squamous Cell Carcinoma. Zhao, Cheng; Wei, Chuang; Chen, Xiatian; Li, Peifeng Jul 25, 2022 4252
Upregulated Expression of IL2RB Causes Disorder of Immune Microenvironment in Patients with Kawasaki Disease. Liao, Yunfei; Ke, Ben; Long, Xiaoyan; Xu, Jianjun; Wu, Yongbing Jul 25, 2022 7859
mTOR Modulates the Endoplasmic Reticulum Stress-Induced CD4[sup.+] T Cell Apoptosis Mediated by ROS in Septic Immunosuppression. Wang, Hao; Chen, Jianwei; Bai, Guangxu; Han, Wen; Guo, Ran; Cui, Na Jul 23, 2022 6502
Cognition/Psychological Burden and Resilience in Cutaneous T-Cell Lymphoma and Psoriasis Patients: Real-Life Data and Implications for the Treatment. Damiani, Giovanni; Tacastacas, Joselin D.; Wuerz, Timothy; Miller, Lindsay; Fastenau, Philip; Bailey Jul 21, 2022 6298
Covaxin booster dose dramatically increases neutralizing antibody responses: Study. Jul 21, 2022 386
In8bio announces issuance of European patent covering matter for DRI platform. Jul 21, 2022 282
Sangamo gets EC OMPD to CAR-Treg cell therapy TX200 for organ transplantation. Jul 21, 2022 238
European Orphan Medicinal Product Designation Granted to Sangamo Therapeutics Investigational CAR-Treg Cell Therapy TX200 for Solid Organ Transplantation. Jul 21, 2022 434
BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity. Liu, Junxiu; Tian, Tian; Liu, Xiangyu; Cui, Zhumei Jul 21, 2022 7917
Wugen Receives US FDA Fast Track and Rare Pediatric Disease Designations for WU-CART-007 for the Treatment of R/R T-ALL/LBL. Jul 19, 2022 383
Bioinformatics Analysis Reveals an Association between Autophagy, Prognosis, Tumor Microenvironment, and Immunotherapy in Osteosarcoma. Ma, Yibo; Tong, Changgui; Xu, Mingjun; He, Hongtao; Chen, Changjian Jul 14, 2022 5561
NeoImmuneTech's NT-I7 receives US FDA Orphan Drug Designation. Jul 14, 2022 316
NeoImmuneTech's NT-I7 receives US FDA Orphan Drug Designation. Jul 14, 2022 315
Top doctor explains why everyone must get a booster jab. Jul 14, 2022 263
Atara Biotherapeutics Completes the ATA188 Phase 2 EMBOLD Study Interim Analysis in Patients with Progressive MS. Clinical report Jul 13, 2022 607
SQZ Biotechnologies and Collaborators Publish Technology Review on SQZ APCs and Effective CD8 T Cell Activation. Jul 13, 2022 637
Identification of APC Mutation as a Potential Predictor for Immunotherapy in Colorectal Cancer. Feng, Fen; Sun, Huake; Zhao, Zhikun; Sun, Chao; Zhao, Yongtian; Lin, Hanqing; Yang, Jie Jul 13, 2022 4484
Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer. Liu, Guiyuan; Chen, Dehu; Zhao, Xiaojun; You, Xiaolan; Huang, Chuanjiang; Cheng, Zhiyi; Mao, Xunan Jul 12, 2022 4095
SQZ Biotechnologies announces publication of review on APCs. Jul 12, 2022 166
TScan Therapeutics announces publication highlighting tumor antigens, TCRs. Jul 11, 2022 304
Immunocore announces dosing of first patient with ImmTAV bispecific for HIV. Jul 11, 2022 212
Electroacupuncture at Zusanli (ST36), Guanyuan (CV4), and Qihai (CV6) Acupoints Regulates Immune Function in Patients with Sepsis via the PD-1 Pathway. Yang, Guang; Zheng, BoJun; Yu, Yi; Huang, Jing; Zhu, HongFa; Deng, DingWei; Li, Jian Report Jul 11, 2022 6367
Study on the Prognostic Values of TTC36 Correlated with Immune Infiltrates and Its Methylation in Hepatocellular Carcinoma. Jing, Wei; Peng, Ruoyu; Li, Xiaogai; Lv, Shaogang; Duan, Yu; Jiang, Shitao Report Jul 8, 2022 4738
FDA Grants Priority Review to Genentech's Mosunetuzumab for People with Relapsed or Refractory Follicular Lymphoma. Jul 7, 2022 824
CD226 Deficiency Alleviates Murine Allergic Rhinitis by Suppressing Group 2 Innate Lymphoid Cell Responses. Xie, Yang; Zhang, Yuan; Zhu, Tianxiao; Ma, Jingchang; Duan, Chujun; Yang, Lu; Wang, Tingting Jul 7, 2022 6373
Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer. Li, Wei; Lu, Zhe; Pan, Dongqing; Zhang, Zejian; He, Hua; Wu, Jiacheng; Peng, Naixiong Jul 6, 2022 6316
SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer. Yu, Pengcheng; He, Weiyang; Zhang, Yanqiang; Hu, Can; Wu, Yue; Wang, Yi; Bao, Zhehan Jul 5, 2022 6799
Immunomodulatory Effects of Lepidium meyenii Walp. Polysaccharides on an Immunosuppression Model Induced by Cyclophosphamide. Fei, Wen-ting; Yue, Na; Li, Ai-min; Yu, Shu-hui; Zhao, Dan-ping; Zhu, Ying-li; Wang, Chun Jul 4, 2022 7202
EDUCATION CITY STUDENTS HONE SKILLS IN FUTURE LEARNING ACADEMY HOSTED BY QF PARTNER TEXAS A&M AT QATAR. Jul 3, 2022 626
Education City students hone skills in Future Learning Academy hosted by Tamuq. Jul 2, 2022 620
Immune Targeted Therapies for COVID-19 Infection: A Narrative Review. Forouzani-Haghighi, Bahareh; Rezvani, Alireza; Vazin, Afsaneh Jul 1, 2022 5466
SQZ DEBUTS INTEGRATED POC CELL THERAPY SYSTEM. Clinical report Jul 1, 2022 940
Cyclacel Pharmaceuticals achieves key business objectives in 1H22. Jun 30, 2022 350
Effect of Montelukast sodium combined with Budesonide aerosol on airway function and T lymphocytes in asthmatic children. Wei Jin, Zichong Zhao and Dongping Zhou Jun 30, 2022 2741
Gingiva-Derived Mesenchymal Stem Cells Attenuate Imiquimod- (IMQ-) Induced Murine Psoriasis-Like Skin Inflammation. Ye, Ziyu; Liang, Yanfang; Lin, Bihua; Li, Yanyun; Chai, Xingxing; Lian, Jiachun; Zhang, Xueying Jun 30, 2022 6234
A Risk Model Based on Sorafenib-Response Target Genes Predicts the Prognosis of Patients with HCC. Liu, Xiang; Zeng, Jian; Li, Huanyu; Li, Feng; Jiang, Bin; Zhao, Ming; Liu, Zhuo Jun 28, 2022 7260
A Novel Angiogenesis-Related Gene Signature to Predict Biochemical Recurrence of Patients with Prostate Cancer following Radical Therapy. Fan, Bohan; Wang, Yicun; Zheng, Xin; Zhang, Xin; Zhang, Zijian; Hu, Xiaopeng Jun 28, 2022 6696
Integrated Single-Cell RNA-Sequencing Analysis of Gastric Cancer Identifies FABP1 as a Novel Prognostic Biomarker. Yang, Fan; Gan, Lianfang; Pan, Junhua; Chen, Yaying; Zhang, Hong; Huang, Ling Jun 28, 2022 5955
Fate Therapeutics announces expansion of collaboration with ONO Pharmaceutical. Jun 28, 2022 252
Effects of tumor derived exosomes on T cells markers expression/Efeitos de exossomos derivados de tumor na expressao de marcadores de celulas T. Hussain, S.; Malik, S.I. Jun 28, 2022 5000
Alaunos Therapeutics, NCI expand CRADA to 2025. Jun 27, 2022 158
Immunocore announces initial data from Phase 1 ImmTAV trial. Jun 26, 2022 340
An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer. Huang, Changchang; Cui, Hongyin; Lang, Xiaolin; Zhao, Fen Jun 26, 2022 3892
gp96 Expression in Gliomas and Its Association with Tumor Malignancy and T Cell Infiltrating Level. Li, Chunzhao; Wang, Yi; Long, Lang; Zhang, Peng; Zhang, Yang; Ji, Nan Jun 26, 2022 7094
Construction of Metabolic Molecular Classification and Immune Characteristics for the Prognosis Prediction of Ovarian Cancer. Wang, Kexin; He, Hui; Feng, Xue Jun 25, 2022 8514
Analysis on the Efficacy of Bronchial Artery Chemoembolization Combined with 125I Seed Implantation in the Therapy of Advanced Non-Small-Cell Lung Cancer Based on the Medical Database. Xie, Peng; He, Lidong; Zhang, Yan Report Jun 24, 2022 4388
US FDA Approves Bristol Myers Squibb's CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy. Jun 24, 2022 520
A breakthrough in Hemo-Oncology. Jun 24, 2022 584
BioNTech receives PRIME designation for BNT211 in testicular cancer. Jun 23, 2022 222
Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis. Huang, Zhehao; Wang, Hailiang; Sun, Dongjie; Liu, Jun Report Jun 23, 2022 5805
SNHG5/miR-299-5p/ATF2 Axis as a Biomarker in Immune Microenvironment of Intervertebral Disc Degeneration. Shi, Yu; Guo, Rong; Zeng, Yanyan; Fang, Qian; Wang, Xianglong; Liu, Wei; Huang, Guozhi Jun 23, 2022 6177
Osimertinib Improves the Immune Microenvironment of Lung Cancer by Downregulating PD-L1 Expression of Vascular Endothelial Cells and Enhances the Antitumor Effect of Bevacizumab. Xiao, Xuejun; Wu, Yang; Shen, Fang; MuLaTiAize, Yusufu; Xinhua, Nabi Jun 23, 2022 4944
Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD[sub.3]+CD[sub.56]+ NKT-Like Cells. Zhu, Siyu; Zhang, Chen; Sun, Qian; Wang, Yang; Yu, Wenwen; Wei, Feng; Ren, Xiubao Jun 23, 2022 5590
Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors. Zhang, Mengqi; Wang, Lulu; Liu, Wan; Wang, Tian; De Sanctis, Francesco; Zhu, Lifang; Zhang, Guizhong Jun 22, 2022 10540
Mustang Bio announces FDA granted ODD to MB-106. Jun 22, 2022 188
General Construction Company uses Terex Cranes for Dubai Creek development. Mark Dowdall Jun 21, 2022 389
General Construction Company uses Terex Cranes for Dubai Creek development. Mark Dowdall Jun 21, 2022 408
Acepodia's ACE1831 Investigational New Drug application receives FDA approval to commence phase one first-in-human, multi-centre clinical study. Jun 21, 2022 235
Acepodia's ACE1831 Investigational New Drug application receives FDA approval to commence phase one first-in-human, multi-centre clinical study. Jun 21, 2022 234
EMA validates Bristol-Myers application for CAR T cell therapy Breyanzi. Jun 20, 2022 349
T Cell Roles and Activity in Chronic Sclerosing Sialadenitis as IgG4-Related Disease: Current Concepts in Immunopathogenesis. Ibrahem, Hazim Mahmoud Jun 20, 2022 15196
Integrated Bioinformatic Analysis of DNA Methylation and Immune Infiltration in Endometrial Cancer. Dai, Fangfang; Wu, Jinglin; Deng, Zhimin; Li, Hengxing; Tan, Wei; Yuan, Mengqin; Yang, Dongyong; Liu Report Jun 20, 2022 4692
CD96 Downregulation Promotes the Immune Response of CD4 T Cells and Associates with Ankylosing Spondylitis. Wu, Fengqing; Yang, Huan; Xu, Xiao; Ren, Conglin; Zheng, Yang; Zhang, Helou; Cai, Bingbing Report Jun 19, 2022 6503
The Potential Diagnostic Value of Immune-Related Genes in Interstitial Fibrosis and Tubular Atrophy after Kidney Transplantation. Yang, Bin; Shi, Dike; Chen, Yahong; Zhu, Yi Jun 17, 2022 7218
Prediction of Immune Infiltration Diagnostic Gene Biomarkers in Kawasaki Disease. Ba, Hongjun; Wang, Yao; Zhang, Lili; Wang, Huishen; Huang, Zhan-Peng; Qin, Youzhen Jun 17, 2022 6069
Kymera Therapeutics doses first patients in Phase 1 clinical trials assessing KT-333 and KT-413. Jun 17, 2022 176
Kymera Therapeutics doses first patients in Phase 1 clinical trials assessing KT-333 and KT-413. Jun 17, 2022 177
Sana presents data at ISSCR 2022 on transplanted allogeneic, hypoimmune cells. Jun 17, 2022 398
Total skin electron beam therapy (TSEBT) in management of mycosis fungoides: A case series. Jun 16, 2022 1605
Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant Tissue. Nguyen, Linh T.; Lo, Charlotte S.; Fyrsta, Michael; Nie, Jessica; Yam, Jennifer Y.; Yen, Pei-Hua; Le Jun 16, 2022 6301
Kymera Therapeutics begins dosing in Phase 1 oncology trials of KT-333, KT-413. Jun 15, 2022 163
Affini-T Therapeutics, Metagenomi Forge Gene Editing Partnership to Advance Cell Therapies for Solid Tumor Patients. Jun 15, 2022 244
lncRNA FR215775 Regulates Th2 Differentiation in Murine Allergic Rhinitis. Ma, Yue; Shi, Le; Zhao, Keqing; Zheng, Chunquan Jun 14, 2022 5405
LNCRNA XIST Inhibits miR-377-3p to Hinder Th17 Cell Differentiation through Upregulating ETS1. Yao, Chen; Li, Chao; Liu, Zhijia; Xiao, Li; Bai, Hongwei; Shi, Bingyi Jun 14, 2022 3232
Identification of Biomarkers Associated with Diagnosis of Osteoarthritis Patients Based on Bioinformatics and Machine Learning. Liang, Yihao; Lin, Fangzheng; Huang, Yunfei Jun 13, 2022 4201
Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer. Shi, Jie; Yang, Xu; Wang, Xinmei; Luo, Yufeng; Zhou, Weixun; Luo, Hanhuan; Bianba, Zhaxi Report Jun 13, 2022 7957
Mustang Bio announces updated interim data on Phase 1/2 trial of MB-106. Jun 13, 2022 300
Homology Medicines says FDA lifts clinical hold on pheNIX gene therapy trial. Jun 13, 2022 189
Scientists discover the best way to protect yourself against Covid; So which is 'better' -the immunity produced from an infection or a vaccine? By, Grace C Roberts, University of Leeds & Lena Glaser, Queen's University Belfast Jun 13, 2022 1075
Scientists discover the best way to protect yourself against Covid; So which is 'better' -the immunity produced from an infection or a vaccine? By, Grace C Roberts, University of Leeds & Lena Glaser, Queen's University Belfast Jun 13, 2022 1075
Genmab announces Phase 2 results of epcoritamab in relapsed/refractory LBCL. Financial report Jun 12, 2022 375
Crispr Therapeutics presents results from Phase 1 COBALT-LYM trial of CTX130. Jun 12, 2022 440
lncRNA SNHG15 as a ceRNA modulates Osteoclast Differentiation, Proliferation, and Metastasis by Sponging miR-381-3p/NEK2 Axis. Wang, YiFan; Zhu, GuanYin; Pei, Fang; Zhao, ZhiHe Jun 12, 2022 5156
Integrated Bioinformatics Identifies FREM1 as a Diagnostic Gene Signature for Heart Failure. Jiang, Chenyang; Jiang, Weidong Jun 11, 2022 4969
Breakthrough in cancer care. Jun 11, 2022 187
Thymus cancer: Four everyday health issues that could be a warning sign; Some common health complaints are easy to ignore or blame on other factors, but not speaking to your GP about these issues could mean missing an early cancer diagnosis. Cancers of the thymus gland can affect your airways, leading to wheezing and feeling dizzy. By, William Morgan Jun 11, 2022 567
Sonoma Biotherapeutics Receives FDA Clearance of Investigational New Drug Application for SBT115301, an Effector T Cell-Modulating Biologic for Autoimmune Diseases. Jun 10, 2022 232
Gritstone announces results from preclinical study of samRNA vaccine. Jun 10, 2022 187
UK's CrowdToLive, Qatar's Al Adaam Real Estate joining forces. Jun 9, 2022 336
Updated Data for Janssen's Bispecific Teclistamab Suggest Continued Deep and Durable Responses in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma. Jun 8, 2022 1024
miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma. Lu, Xiaoyuan; Jing, Li; Liu, Sicong; Wang, Haihong; Chen, Buze Jun 8, 2022 8073
Blood Stasis Syndrome Accelerates the Growth and Metastasis of Breast Cancer by Promoting Hypoxia and Immunosuppressive Microenvironment in Mice. Jin, Lu; Tang, Biqiang; Liu, Xia; Mao, Weiye; Xia, Linying; Du, Yueguang; Ji, Bing Jun 7, 2022 6157
Kiromic BioPharma expands Gamma Delta T cell product pipeline. Jun 7, 2022 274
Immatics, Editas Medicine announce strategic collaboration and licensing pact. Jun 7, 2022 223
Adicet Bio outlines data from ADI-001 study at ASCO meeting. Jun 6, 2022 289
In8bio announces safety, durability data from Phase 1 trial of INB-200. Jun 6, 2022 396
Portage Biotech presents early data from Phase 1/2 study of PORT-2. Jun 6, 2022 210
Kite announces longer-term follow-up results from Tecartus studies. Jun 5, 2022 503
Hookipa Pharma announces Phase 1 data, Phase 2 plans for HB-200 program. Jun 5, 2022 644
TC BioPharm Prices USD 4M Underwritten Public Offering. Jun 3, 2022 206
TC BioPharm Prices USD 4M Underwritten Public Offering. Jun 3, 2022 204
Immatics, Bristol-Myers expand alliance to pursue TCR-T and/or CAR-T programs. Jun 2, 2022 235
Regeneron plans to buy Sanofi's stake in collaboration on Libtayo. Jun 2, 2022 453
T-cell experiment shrinks tumors. LAURAN NEERGAARD AP Medical Writer Jun 2, 2022 246
IL6 Induces mtDNA Leakage to Affect the Immune Escape of Endometrial Carcinoma via cGAS-STING. Zeng, Xue; Li, Xiaosong; Zhang, Yundong; Cao, Chaoxia; Zhou, Qin Jun 2, 2022 6242
Calorie Restriction Can Positively Affect Immune Health. Jun 1, 2022 167
Kymera Therapeutics to present preclinical data at EULAR 2022 Congress. Jun 1, 2022 180
Eureka Therapeutics, City of Hope Treat First Patient with GPC3 Targeting ARTEMIS T Cells for Advanced Liver Cancer. Jun 1, 2022 364
Flow Cytometric Detection of the Double-Positive ([CD4.sup.+][CD8.sup.+])/[PD-1.sup.bright] T-Cell Subset Is Useful in Diagnosing Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Chen, Zhongchuan Will; Wizniak, Juanita; Shang, Chuquan; Lai, Raymond Report Jun 1, 2022 7418
Janux Therapeutics Receives FDA Clearance of Investigational New Drug Application for JANX007, a PSMA-TRACTr for Metastatic Castration-Resistant Prostate Cancer. May 31, 2022 350
Perianal ulcerative tuberculosis: A case report. Lao, Weifeng; Mao, Weifang Clinical report May 31, 2022 1649
Serum Scavenging Capacity and Folliculogenesis Impact following Flaxseed Consumption in the First-Generation Mice Pups. Pourjafari, Fahimeh; Haghpanah, Tahereh; Grazia Palmerini, Maria; Ezzatabadipour, Massood May 30, 2022 4452
Novartis' Kymriah CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma receives FDA approval. May 30, 2022 165
Novartis' Kymriah CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma receives FDA approval. May 30, 2022 166
Therapeutical Significance of Serpina3n Subsequent Cerebral Ischemia via Cytotoxic Granzyme B Inactivation. Aslam, Mehwish Saba; Aslam, Mobeena Saba; Aslam, Komal Saba; Iqbal, Asia; Yuan, Liudi Report May 29, 2022 6706
Clinical Factors of Blood Transfusion-Related Acute Lung Injury and Changes in Levels of Treg-Related Cytokines. Sun, Lifang; Liu, Yu May 27, 2022 3478
LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting. May 27, 2022 514
Bolt Biotherapeutics to present ex vivo data on myeloid cell landscape. May 27, 2022 177
Osivax Provides Clinical Development Update on Lead Influenza Vaccine Candidate OVX836. May 26, 2022 670
Bristol-Myers' Breyanzi ASCO data to show 'substantial durable response' in LBCL. May 26, 2022 225
PDS Biotechnology announces presentation of Phase 2 data on PDS0101 at ASCO. May 26, 2022 165
Bone Mesenchymal Stem Cell-Derived Exosome-Enclosed miR-181a Induces CD4[sup.+]CD25[sup.+]FOXP3[sup.+] Regulatory T Cells via SIRT1/Acetylation-Mediated FOXP3 Stabilization. Wang, Renyong; Li, Ruixue; Li, Tiehan; Zhu, Lei; Qi, Zongze; Yang, Xiaokui; Wang, Huan May 26, 2022 4685
Revisited Cyclophosphamide in the Treatment of Lupus Nephritis. Quan, Xiao-ying; Chen, Hao-tao; Liang, Si-qin; Yang, Chen; Yao, Cui-wei; Xu, Yong-zhi; Liu, Hua-feng Report May 26, 2022 8112
Long-Term GAD-alum Treatment Effect on Different T-Cell Subpopulations in Healthy Children Positive for Multiple Beta Cell Autoantibodies. Salami, Falastin; Spiliopoulos, Lampros; Maziarz, Marlena; Lundgren, Markus; Brundin, Charlotte; Ben May 25, 2022 6112
Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia. Lee, Le Jie; Hassan, Norfarazieda; Idris, Siti Zuleha; Subbiah, Suresh Kumar; Seow, Heng Fong; Mohta May 23, 2022 9128
Novel Immunotherapy Developed by City of Hope Could Provide New Treatment Model for SARS-CoV-2 Patients. May 23, 2022 592
LATEST COMPANY NEWS. May 23, 2022 22635
Machine Learning-Based Integration Develops a Pyroptosis-Related lncRNA Model to Enhance the Predicted Value of Low-Grade Glioma Patients. Wu, Jie; Lu, Lichun; Wang, Chen; Jiang, Feng May 19, 2022 6038
Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature. Ji, Dan; Zhong, Rongfang; Fan, Song Report May 19, 2022 9190
TScan Therapeutics presents preclinical data from solid tumor program. May 19, 2022 840
Allogene Therapeutics presents preclinical data on allogeneic CAR T cells. May 19, 2022 286
Atara provides update on Bayer collaboration. May 19, 2022 295
TC Biopharm forms scientific advisroy board for cell therapy development. May 18, 2022 158
Osivax Enters Research Collaboration with the NIAID for the Evaluation of Combination Approach to Broad-Spectrum Influenza Vaccines. May 18, 2022 509
A Mechanistic Insight into the Pathogenic Role of Interleukin 17A in Systemic Autoimmune Diseases. Bisoendial, Radjesh; Lubberts, Erik May 17, 2022 12695
In8bio announces data emerging from iPSC-based gamma-delta T cell platform. May 17, 2022 230
Poseida Therapeutics to present data from anti-c-kit CAR-T cells studies. May 17, 2022 216
FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma. Wu, Shaobo; Liang, Yuxia; Zang, Qijuan; Xing, Zixuan; Yin, Pan; Sun, Ruifang; Dai, Bingling May 14, 2022 5575
Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer. Wei, Cheng; Li, Minzhe; Lin, Shaofeng; Xiao, Jun Report May 13, 2022 7611
Kiromic BioPharma reports Q1 EPS (48c) vs. (53c) last year. Financial report May 13, 2022 154
Mustang Bio says MB-106 trial selected for oral presentation at EHA2022. May 12, 2022 244
Mustang Bio reports Q1 EPS (20c) vs. (19c) last year. Financial report May 12, 2022 209
Fourth Covid vaccine provides 'a substantial boost to immunity', according to new study; Several countries have now deployed fourth doses of the Covid-19 vaccine, but the clinical need, effectiveness, timing, and dose of a fourth dose remain uncertain. By, Jess Knibbs May 12, 2022 653
Abrine Elicits Liver Carcinoma Immunity and Enhances Antitumor Efficacy of Immune Checkpoint Blockade by Modulating PD-L1 Signaling. Zhang, Shaowu May 12, 2022 5425
hsa-miR-9-5p-Mediated TSPAN9 Downregulation Is Positively Related to Both Poor Hepatocellular Carcinoma Prognosis and the Tumor Immune Infiltration. Tan, Shengkui; Song, Xin; Zhang, Chenchen; Sun, Yishu; Zhang, Jiaxi; Zhang, Zhongqi; Zhang, Rongchen May 12, 2022 5234
The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors. Chang, Guodong; Chen, Yingwei; Liu, Zichang; Wang, Yong; Ge, Wenkun; Kang, Yongan; Guo, Shuling May 12, 2022 4682
Comprehensive Analysis of PDLIM3 Expression Profile, Prognostic Value, and Correlations with Immune Infiltrates in Gastric Cancer. Hu, Xinpeng; Chen, Minfeng; Ruan, Qiang; Shi, Changzheng; Pan, Jinghua; Luo, Liangping May 12, 2022 8206
Rationale for the Use of Cord Blood in Hypoxic-Ischaemic Encephalopathy. Zdolinska-Malinowska, Izabela; Boruczkowski, Dariusz; Holowaty, Dominika; Krajewski, Pawel; Snarski, May 11, 2022 10300
Corvus Pharmaceuticals provides updates at R&D symposium. May 10, 2022 225
Adicet Presents Preclinical Data Highlighting Potential Advantages of the Non-Gene-Edited Approach for its Investigational Allogeneic Gamma Delta CAR T Cell Therapy Targeting CD20 for B Cell Malignancies. May 10, 2022 294
Epigenetic Regulation of IFI44L Expression in Monocytes Affects the Functions of Monocyte-Derived Dendritic Cells in Systemic Lupus Erythematosus. Luo, Shuaihantian; Wu, Ruifang; Li, Qianwen; Zhang, Guiying May 10, 2022 5694
Crosstalk between ILC2s and Th2 CD4[sup.+] T Cells in Lung Disease. Mi, Lan-lan; Guo, Wei-wei May 10, 2022 11623
Achilles Therapeutics doses first patient with higher dose cNeT in trial. May 9, 2022 199
Equillium announces three poster presentations at IMMUNOLOGY2022. May 9, 2022 586
Enlivex Therapeutics announces poster presentation of data on Allocetra. May 9, 2022 308
A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective. Bao, Haili; Luo, Yi; Ding, Guoshan; Fu, Zhiren May 7, 2022 7677
AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer. Li, Xubin; Zhang, Mengqiao; Yu, Xue; Xue, Mei; Li, Xiaowei; Ma, Chao; Jia, Wei May 7, 2022 4716
Development of a Clinically Oriented Model to Predict Antitumor Effects after PD-1/PD-L1 Inhibitor Therapy. Wang, Xueping; He, Zhonglian; Liu, Wen; Han, Runkun; Li, Huilan; Dai, Shuqin; Zhang, Lin May 4, 2022 4996
My little miracle, by new mum saved by Christie; CANCER PATIENT SAVED FROM INFERTILITY THANKS TO NEW TREATMENT. PAUL BRITTON May 3, 2022 598
BABY I FEARED I'D NEVER HAVE; Cancer therapy mum's miracle. AMY-CLARE MARTIN May 3, 2022 192
Cancer survivor who feared she was infertile gives birth after innovative cell therapy; Sammy Gray is one of the first women to give birth after receiving innovative new treatment for non-Hodgkin's Lymphoma after she received the heartbreaking cancer diagnosis in 2018. By, Amy-Clare Martin May 3, 2022 209
Inmagene Biopharmaceuticals receives USFDA approval over Phase one clinical development of IMG-007. May 2, 2022 171
Intellia presents preclinical data on CRISPR-engineered allogeneic platform. May 2, 2022 215
CERo Therapeutics' Multifunctional CER T Cells Synergize with Standard-of-Care Small Molecule Anti-Tumor Inhibitors Across Hematologic and Solid Tumor Models. May 2, 2022 440
Inflammatory cells in the ascending aortic aneurysm in patients with type 2 diabetes versus patients with hypertension. Milutinovic, Aleksandra; Zorc-Pleskovic, Ruda Report May 1, 2022 4903
Altered molecular pathways and prognostic markers in active systemic juvenile idiopathic arthritis: Integrated bioinformatic analysis. Ren, Yi; Labinsky, Hannah; Palmowski, Andriko; Backer, Henrik; Muller, Michael; Kienzle, Arne Report Apr 30, 2022 7377
Role of CD4[sup.+]T, CD8[sup.+]T Cells, and CD4[sup.+]T/CD8[sup.+]T Cell Ratio in Gastric Cancer and Its Clinical Significance. Han, Jingqi; Zhao, Linglin; Wu, Jianying; Diao, Yinzhuo; Guo, Qijing; Yang, Jie; Luo, Yushuang Apr 30, 2022 6154
IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer. Li, Guangyao; Wang, Yandong; Cheng, Ya Apr 29, 2022 7025
Factors Affecting the Readmission of Patients with Pancreatic Cancer after Surgery. Gu, Xiaojing; Zhou, Wei; Han, Juan Apr 29, 2022 3985
Bone Marrow-Derived Cells Contribute to the Maintenance of Thymic Stroma including TECs. Chakrabarti, Shami; Hoque, Mohammed; Jamil, Nawshin Zara; Singh, Varan J.; Pollacksmith, Daniel; Mee Apr 29, 2022 12975
Scientists explore link between vitamin D, inflammation in Covid patients. Apr 29, 2022 413
ISMAIL MOSTAFA AND YOUSSEF MAHMOUD RECEIVE CTL AWARD FOR OUTSTANDING PERFORMANCE. Apr 28, 2022 208
Cellectis publishes two articles on UCART123. Apr 28, 2022 266
lncRNA STAT4-AS1 Inhibited TH17 Cell Differentiation by Targeting ROR? t Protein. He, Hanlin; Qiu, Xiangjie; Qi, Mingming; Bajinka, Ousman; Qin, Ling; Tan, Yurong Apr 28, 2022 7581
Different In Situ Immune Patterns between Primary Tumor and Lymph Node in Non-Small-Cell Lung Cancer: Potential Impact on Neoadjuvant Immunotherapy. Ye, Zheng-Hao; Long, Hao; Zhao, Ze-Rui Apr 28, 2022 7617
The Diagnostic and Predictive Significance of Immune-Related Genes and Immune Characteristics in the Occurrence and Progression of IgA Nephropathy. Qing, Jian-Bo; Song, Wen-Zhu; Li, Chang-Qun; Li, Ya-Feng Apr 28, 2022 7102
Spatiotemporal Dynamics of a Delayed Viral Infection Model with Two Modes of Transmission and Immune Impairment. Miao, Hui; Jiao, Meiyan Apr 26, 2022 5793
The Temporal and Spatial Changes of Th17, Tregs, and Related Cytokines in Epilepsy Lesions. Wei, Jingbo; Liu, Hui; Liu, Ziqi; Jiang, Xiaohua; Wang, Weiping Apr 26, 2022 5389
CTL RECOGNIZES SIS AND PEER TUTORS. Apr 26, 2022 280
LANCL1 as the Key Immune Marker in Neuropathic Pain. Shi, Yu; Zhang, XueFei; Fang, Qian; Zhan, Hongrui; Wang, Xianglong; Huang, Xiyan; Fan, Tao Apr 25, 2022 5083
Suzhou Porton Advanced Solutions and Guizhou Sinorda Biomedicine enter into long-term strategic partnership. Apr 25, 2022 153
Suzhou Porton Advanced Solutions and Guizhou Sinorda Biomedicine enter into long-term strategic partnership. Apr 25, 2022 154
Nkarta announces preliminary dose finding data for two NK cell programs. Apr 25, 2022 255
Mustang Bio announces updated interim Phase 1/2 data for MB-106. Apr 25, 2022 258
Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives. Liang, Jiaqi; Bi, Guoshu; Shan, Guangyao; Jin, Xing; Bian, Yunyi; Wang, Qun Apr 22, 2022 10130
AIM ImmunoTech provides summary of data from checkpoint blockade therapies. Apr 21, 2022 319
Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T. Apr 21, 2022 370
Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer via FOSB-Mediated Downregulation of MicroRNA-22 through BATF3/PD-L1 Pathway. Tian, Jiale; Wang, Weiwei; Zhu, Jichao; Zhuang, Yun; Qi, Chunrun; Cai, Zhengxin; Yan, Wenhui Apr 20, 2022 7814
Revealing Potential Diagnostic Gene Biomarkers Associated with Immune Infiltration in Patients with Renal Fibrosis Based on Machine Learning Analysis. Sun, Yu-Chao; Qiu, Zhen-Zhen; Wen, Fu-Li; Yin, Jin-Quan; Zhou, Hao Report Apr 20, 2022 5083
Kite Receives US FDA Approval of New CAR T-Cell Therapy Manufacturing Facility in Maryland. Apr 20, 2022 523
Humanigen's lenzilumab reduces cytokine release syndrome in published study. Apr 20, 2022 198
Kite gets FDA approval of CAR T-cell therapy manufacturing facility in Maryland. Apr 19, 2022 424
Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19. Alsalman, Alhasan; Al-Mterin, Mohammad A.; Elkord, Eyad Apr 19, 2022 11606
Covid-19 will not cause AIDS like HIV does, says top virologist. Apr 18, 2022 207
Considering Computational Mathematics IGHG3 as Malignant Melanoma Is Associated with Immune Infiltration of Malignant Melanoma. Si, Mengqing; Cao, Xianwei Report Apr 18, 2022 7508
Subcellular Proteome Analysis Reveals Apoptotic Vulnerability of T-Cell Acute Lymphoblastic Leukemia. Song, Xiaolei; Wu, Xiaojing; Zhang, Zihan; Cui, Zhangxiu; Zheng, Yong; Sun, Jian Report Apr 15, 2022 5090
Comprehensive Bioinformatics Analysis of Gasdermin Family of Glioma. Zi, Huaduan; Tuo, Zhan; He, Qianyuan; Meng, Jingshu; Hu, Yan; Li, Yan; Yang, Kunyu Apr 15, 2022 7437
Role of Apoptosis in HIV Pathogenesis. Jabea Ekabe, Cyril; Asaba Clinton, Njinju; Agyei, Eugene Kusi; Kehbila, Jules Apr 14, 2022 7906
Proteomic Profiling and Functional Analysis of B Cell-Derived Exosomes upon Pneumocystis Infection. Ma, Dan; Zhang, Qian-Yu; Rong, Heng-Mo; Zhai, Kan; Tong, Zhao-Hui Apr 14, 2022 9231
Novel Covid vax may provide protection for cancer patients. Apr 14, 2022 386
Novel Covid vax may provide protection for cancer patients. Apr 14, 2022 386
Osivax welcomes new board member & announces upcoming presentation at World Vaccine Congress. Apr 14, 2022 154
Osivax welcomes new board member & announces upcoming presentation at World Vaccine Congress. Apr 14, 2022 155
Oncolytics' pelareorep shows anti-cancer potential in publication. Apr 14, 2022 158
Allogene Therapeutics announces unveiling of Cell Forge 1. Apr 14, 2022 179
SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo. Apr 14, 2022 698
Allogene Therapeutics publishes preclinical data on ALLO-316. Apr 13, 2022 240
Mustang Bio plans to initiate Phase 1 trial combining MB-101 with MB-108. Apr 13, 2022 450
Portage Biotech highlights data presented on PORT-5 at AACR 2022. Apr 13, 2022 207
Hookipa Pharma announces preclinical data on arenaviral immunotherapies. Apr 13, 2022 499
Cross Talk between Inflammation and Metabolic Disorders. Chen, Jie; Yang, Yan; Kong, Wen Apr 13, 2022 1317
Sarcoidosis: An experience from a tertiary care center in Karachi Pakistan. Khan, Mustafa Ali; Ibad, Hamza Ahmed; Hussain, Sahibzada Muhammad Hamid; Hassan, Maryam; Ali, Akbar Report Apr 13, 2022 2279
Prediction of Prognosis and Recurrence of Bladder Cancer by ECM-Related Genes. Zhao, Hongfan; Chen, Zihao; Fang, Yunze; Su, Mingqiang; Xu, Yipeng; Wang, Zhifeng; Gyamfi, Michael A Apr 12, 2022 8722
Training T-cells how to destroy breast cancer; Cardiff University professor Awen Gallimore explains her pioneering work investigating how we can help our immune systems recognise and destroy breast cancer... Apr 12, 2022 697
Simple delivery method that enhances a promising cancer treatment. Apr 12, 2022 456
Achilles Therapeutics announces manufacturing expansion in UK, US. Apr 12, 2022 173
Harpoon Therapeutics presents preclinical data for TriTAC-XR platform. Apr 12, 2022 176
Molecular Templates reviews six poster presentations at AACR 2022 meeting. Apr 12, 2022 422
Scientists Find New Technique to Treat Cancer Tumor. Asharq Al-Awsat Apr 12, 2022 343
AIM reports data from Phase 1 study of Ampligen for treatment of breast cancer. Apr 11, 2022 202
Training T-cells how to destroy breast cancer; Cardiff University professor Awen Gallimore and her team are investigating how we can help our immune systems recognise and destroy breast cancer. Here, she explains more about her pioneering work which she hopes will help lead to more effective treatments for the disease. AgendaWM Edited by Mark Smith 029 2024 3937 mark.smith@walesonline.co.uk Apr 11, 2022 704
BioNTech presents data from BNT211 trial at AACR meeting. Apr 11, 2022 384
Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies. Apr 8, 2022 320
IsoPlexis to present data generated using it Duomic platform. Apr 8, 2022 243
MEI Pharma announces presentations at AACR Annual Meeting. Apr 8, 2022 339
Compass Therapeutics presents data on CTX-8371 at AACR meeting. Apr 8, 2022 227
iTeos Therapeutics presents new data for EOS-448/GSK4428859A. Apr 8, 2022 318
Genocea presents initial data from GEN-011 Phase 1/2a trial. Apr 8, 2022 189
Caribou Biosciences data supports an expected IND application for CB-011 in 2022. Apr 8, 2022 277
Adaptimmune presents MAGE-A4 expression data from screening protocol. Apr 8, 2022 226
Corbus presents first preclinical data for CRB-601 at AACR. Apr 8, 2022 200
Arcellx presents pre-clinical data for ACLX-002 at AACR. Apr 8, 2022 181
Twist in antibody discovery pact for T-cell therapeutics with MediSix. Apr 7, 2022 172
New Paradigm in Cell Therapy Using Sperm Head to Restore Brain Function and Structure in Animal Model of Alzheimer's Disease: Support for Boosting Constructive Inflammation vs. Anti-Inflammatory Approach. Pakravan, Nafiseh; Abbasi, Ardeshir; Hassan, Zuhair Mohammad Apr 7, 2022 10651
Determination of B and T Cell Epitopes in Neospora caninum Immune Mapped Protein-1 (IMP-1): Implications in Vaccine Design against Neosporosis. Nazari, Naser; Kordi, Bahareh; Maleki, Bahman; Shams, Morteza; Azizi, Esfandiar; Majidiani, Hamidrez Report Apr 7, 2022 6824
Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature. Lu, Lin; Zhang, Peiling; Cao, Xiaofei; Guan, Mingmei Apr 6, 2022 7371
Hyper-Methylated Hub Genes of T-Cell Receptor Signaling Predict a Poor Clinical Outcome in Lung Adenocarcinoma. Hu, Zixin; Xue, Chongxiang; Zheng, Jiabin; Lu, Xingyu; Li, Jia; Dong, Huijing; Yu, Yixuan Apr 6, 2022 10099
Effects of Sodium Chlorophyllin Copper on APO-1 Expression in Bone Marrow Mesenchymal Stem Cells of Rats with Aplastic Anaemia. Jin, Xin; Dai, Guanhai; Xuan, Liyang; Zhang, Meng; Jiang, Huifang; Sui, Yang Apr 6, 2022 5216
miR-155: An Important Role in Inflammation Response. Hu, Jingyan; Huang, Songli; Liu, Xiaoli; Zhang, Yuan; Wei, Shengli; Hu, Xiuhua Apr 6, 2022 10515
Neospora caninum SRS2 Protein: Essential Vaccination Targets and Biochemical Features for Next-Generation Vaccine Design. Asghari, Ali; Kordi, Bahareh; Maleki, Bahman; Majidiani, Hamidreza; Shams, Morteza; Naserifar, Razi Report Apr 6, 2022 8347
Fujifilm Buys Atara Biotherapeutics Cell Therapy Manufacturing Facility. Apr 6, 2022 302
Fujifilm Buys Atara Biotherapeutics Cell Therapy Manufacturing Facility. Apr 6, 2022 325
Citius Pharmaceuticals reports data from I/ONTAK trial. Apr 6, 2022 350
Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi for Certain Forms of Relapsed or Refractory Large B-cell Lymphoma. Apr 6, 2022 496
Precigen's PRGN-3006 UltraCAR-T receives US FDA Fast Track designation. Apr 5, 2022 212
Precigen's PRGN-3006 UltraCAR-T receives US FDA Fast Track designation. Apr 5, 2022 213
Tonix extends sponsored research agreement with Kansas State University. Apr 5, 2022 257
Now Muzik set to release Sound Sultan's 9th album. Apr 5, 2022 431
Immunocore announces EC approval of KIMMTRAK. Apr 4, 2022 236
Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer. Liu, Chao; Li, Xiaohui; Li, Aijie; Zou, Wenxue; Huang, Rui; Hu, Xiaoyu; Yu, Jinming Apr 4, 2022 4028
Evolution of Immunity and Immune System in Humans. Anam, Mujibul Apr 1, 2022 773
Immunoglobin G4-Related Diseases. Tinazli, Mehtap; Tinazli, Remzi Apr 1, 2022 4414
Overexpression of miR-490-5p/miR-490-3p Potentially Induces IL-17-Producing T Cells in Patients With Breast Cancer. Seif, Farhad; Vaseghi, Hajar; Ariana, Mehdi; Ganji, Shahla Mohammad; Nazari, Mohammad; Rad, Kowsar K Report Apr 1, 2022 4620
New Vaccine Component May Provide Greater Immune Response. Apr 1, 2022 185
Lymphoproliferative Disorders as Potential Candidates for CD30-Targeted Therapies. Schwarting, Roland; Behling, Eric; Allen, Ashleigh; Arguello-Guerra, Vivian; Budak-Alpdogan, Tulin Report Apr 1, 2022 14849
Assessment of Clonotypic Rearrangements and Minimal Residual Disease in Lymphoid Malignancies: A Large Cancer Center Experience Using clonoSEQ. Hussaini, Mohammad O.; Srivastava, Jaya; Lee, Lik Wee; Nishihori, Taiga; Shah, Bijal D.; Alsina, Mel Report Apr 1, 2022 7653
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination. Dulovic, Alex; Strengert, Monika; Ramos, Gema Morillas; Becker, Matthias; Griesbaum, Johanna; Junker Report Apr 1, 2022 4963
Unique Clinical, Immune, and Genetic Signature in Patients with Borrelial Meningoradiculoneuritis. Ogrinc, Katarina; Hernandez, Sergio A.; Korva, Misa; Bogovic, Petra; Rojko, Tereza; Lusa, Lara; Chiu Report Apr 1, 2022 6710
Govt plans coal conversion to gas, liquid fuels. Mar 31, 2022 781
Surface achieves $30M milestone with first patient dosed in Phase 1 study. Mar 31, 2022 153
Jasper Therapeutics to present updated data on JSP191. Mar 31, 2022 171
Portage Biotech provides update on clinical-stage, development programs. Mar 31, 2022 430
Understanding of Immune Escape Mechanisms and Advances in Cancer Immunotherapy. Aktar, Nasrin; Yueting, Chen; Abbas, Muhammad; Zafar, Hajra; Paiva-Santos, Ana Cláudia; Zhang, Qin; Mar 31, 2022 11813
Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma. Sun, Ji; Cheng, Nan-sheng Mar 30, 2022 4719
A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma. Lai, Xing; Wu, Ya-kun; Hong, Guo-qing; Li, Jun-ke; Luo, Qing; Yuan, Jin; Dai, Guo-hua Mar 30, 2022 4744
Aspirin Suppressed PD-L1 Expression through Suppressing KAT5 and Subsequently Inhibited PD-1 and PD-L1 Signaling to Attenuate OC Development. Xiao, Xiyun; Zeng, Saitian; Li, Yanying; Li, Lingling; Zhang, Jiyan Mar 29, 2022 4124
Sangamo Therapeutics Doses First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation. Clinical report Mar 29, 2022 1015
In8bio presents clinical update on ongoing Phase 1 trial of INB-100. Mar 28, 2022 222
Role and Function of Regulatory T Cell in Chronic Rhinosinusitis with Nasal Polyposis. Lei, Chenyang; Jiang, Juan; Zhang, Yanyan; Xiong, Gaoyun Mar 26, 2022 12204
The Role of PDGFRA in Predicting Oncological and Immune Characteristics in Pancreatic Ductal Adenocarcinoma. Wu, Zijian; Xu, Jin; Tang, Rong; Wang, Wei; Zhang, Bo; Yu, Xianjun; Liu, Jiang Mar 26, 2022 7705
Low Activation of CD8[sup.+] T Cells in response to Viral Peptides in Mexican Patients with Severe Dengue. Estrada-Jiménez, Tania; Flores-Mendoza, Lilian; Ávila-Jiménez, Laura; Vázquez-Rodríguez, Carlos Fran Mar 25, 2022 9056
The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model. Mierzejewska, Jagoda; Wegierek-Ciura, Katarzyna; Rossowska, Joanna; Szczygiel, Agnieszka; Anger-Góra Mar 25, 2022 14056
Govt explains why Oulanyah didn't get treatment in Seattle. Mar 25, 2022 339
Govt explains why Oulanyah didn't get treatment in Seattle. Mar 25, 2022 360
A Bioinformatics Study of Immune Infiltration-Associated Genes in Sciatica. Ma, Tao; Li, Guanhua; Ma, Yuheng; Ren, Zhaoqi; Xie, Houyun; Sun, Chaoyong; Tian, Lei Mar 24, 2022 2566
Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma. Xiang, Jing; Chen, Xiaotong; Chen, Mengping; Hou, Jian Report Mar 23, 2022 8910
Allogene announces preclinical publication results on allogeneic CAR T cells. Financial report Mar 23, 2022 280
LATEST COMPANY NEWS. Mar 23, 2022 20431
Coal conversion to gas, liquid fuels planned. Mar 22, 2022 793
Bimbo Akintola Remembers Late Sound Sultan. Mar 19, 2022 305
TEE GRANT WINNERS ANNOUNCED FOR 2022. Mar 17, 2022 445
Neximmune, Zephyr AI announce strategic partnership in oncology. Mar 17, 2022 264
OSE Immunotherapeutics reports positive long-term memory responses with COVID-19 vaccine candidate CoVepiT. Mar 17, 2022 180
OSE Immunotherapeutics reports positive long-term memory responses with COVID-19 vaccine candidate CoVepiT. Mar 17, 2022 179
Inflammatory Response-Related Long Non-Coding RNA Signature Predicts the Prognosis of Hepatocellular Carcinoma. Li, Xinyu; Zhang, Shuqiao; Zhang, Shijun; Kuang, Weihong; Tang, Chunzhi Mar 17, 2022 5691
DT2216 Receives Orphan Drug Designation from the FDA for the Treatment of T-Cell Lymphoma. Mar 16, 2022 444
Adaptimmune provides update of progress of '2-2-5-2' strategic plan. Mar 14, 2022 211
Bach2: A Key Regulator in Th2-Related Immune Cells and Th2 Immune Response. Liu, Guo; Liu, Feng Mar 12, 2022 7998
Mesenchymal Stem Cell-Secreted TGF-ß 1 Restores Treg/Th17 Skewing Induced by Lipopolysaccharide and Hypoxia Challenge via miR-155 Suppression. Xue, Ming; Zhang, Xiwen; Chen, Jianxiao; Liu, Feng; Xu, Jingyuan; Xie, Jianfeng; Yang, Yi Mar 12, 2022 8925

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |